Atlas Trials

A Study to Assess the Safety, Tolerability and Efficacy of NVA237 Versus Placebo

Clinical trial NCT01005901 · COMPLETED

Trial details

NCT number
NCT01005901
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2009-10-01
Primary completion
2010-12-01
Enrollment
1324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.